2seventy bio, Inc. - Common Stock TSVT 深 沪
已收盘 05-13 16:00:00 美东时间
5.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 5.00
- 总市值 1.88亿
- 52周最高 5.30
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.29
- 委 比 0.00%
- 总股本 3762.24万
- 历史最高 44.34
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Crude Oil Gains 1%; Ciena Earnings Top Views
U.S. stocks traded lower midway through trading, with the Dow Jones falling mor...
03-12 00:02
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more t...
03-11 21:56
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Paymentus Holdings, Inc. (NYSE:PAY) rose sharply in today's pre-marke...
03-11 18:55
2seventy Expects Q3 Abecma US Revenue Growth Of Approximately 30% From Q2 Revenue Of $54M
Demand, as measured by new patients undergoing apheresis in the third quarter, is also expected to reflect double-digit growth when compared to the second quarter of 2024. The Company remains committed to
2024-09-25 18:05
2seventy bio, Bristol Myers Squibb Discontinue Enrollment In Phase 3 KarMMa-9 Study
"With a greatly improved NDMM treatment landscape and following our rigorous review of the business case for the KarMMa-9 study, we have decided to discontinue enrollment in this Phase 3 study," said Chip
2024-09-25 18:03
